Robert McBurney, Lorin Randall, Peter Dansky, Kip Miller, Nicolas Barthelemy, Laura Lauman, David Hoffmeister, Bernd Brust, Peter Leddy, Mark O’Donnell, John Cottingham, Paul Grossman, Joe Beery, Brian Pollock, Mark Smedley | GenomeWeb
TheraGenetics this week announced that it has appointed Robert McBurney to the newly created position of executive VP. In this position, McBurney will be responsible for leading TheraGenetics’ global business development and partnership strategy. Previously, McBurney was senior VP of research and development and chief scientific officer at BG Medicine
 

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.